Degnan Chris 4
4 · UroGen Pharma Ltd. · Filed Oct 9, 2024
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-10-08+13,450→ 13,450 total→ Ordinary Shares (13,450 underlying) - Award
Employee Stock Option (right to buy)
2024-10-08+74,142→ 74,142 totalExercise: $13.11Exp: 2034-10-08→ Ordinary Shares (74,142 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]1/3 of the shares underlying the restricted stock units will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027.
- [F3]1/3 of the shares underlying the stock option will vest on each of October 8, 2025, October 8, 2026 and October 8, 2027.